Seeing Alzheimer's disease

January 12, 2018, University of Minnesota
Credit: University of Minnesota

What if we could diagnose early-stage Alzheimer's disease (AD) by looking into a person's eyes?

A retinal scan technique, developed by researchers in the University's Center for Drug Design (CDD), has the potential to detect AD in its early stages, when treatment may still be possible, and also to allow doctors to trace the progress of treatments and help the 100,000 Minnesotans with AD and their families.

The researchers developed a camera to scan retinas and detect small, soluble aggregates of a protein called A-beta. As AD progresses, the aggregates grow and are eventually deposited in the brain as insoluble clumps called plaques.

"We looked at retinas of [mouse models of AD]," says Bob Vince, CDD director. "We could see the aggregation progress of A-beta."

If the technique proves itself as a way to closely follow AD, it will become of great value to drug discovery companies and long-term clinical care, says Kevin Nickels, a U technology licensing officer.

Science of scattering

In people or mice with early-stage AD, the small A-beta aggregates make retinal cells scatter light beams differently than healthy cells do, a difference the camera detects.

In mice, Vince and colleague Swati More, an assistant professor in CDD, have used the technique to follow the progress of the disease and trace the effects of anti-AD drugs. They have also tested about 20 patients so far, and seek to enroll more in a study of the scans' ability to follow the clinical progression of the disease.

"Advancing this exciting technology will require funding a clinical study of seven to eight years, and this is being discussed with a couple of corporate parties," Nickels notes.

Why test patients early?

"A lot of emphasis today is on getting early AD ," says More. "We could tell patients if treatments are working, or recommend further psychological testing."

Explore further: Alzheimer's detected before symptoms via new eye technology

Related Stories

Alzheimer's detected before symptoms via new eye technology

July 11, 2016
Rockville, Md. Scientists may have overcome a major roadblock in the development of Alzheimer's therapies by creating a new technology to observe—in the back of the eye—progression of the disease before the onset of symptoms. ...

Biomarker may predict early Alzheimer's disease

November 10, 2017
Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a peptide that could lead to the early detection of Alzheimer's disease (AD). The discovery, published in Nature Communications, may ...

Findings could lead to early diagnosis of Alzheimer's

September 26, 2017
Korean researchers have identified the cause of olfactory dysfunction in the early stage of Alzheimer's diseases. It is expected to be used in early diagnosis of Alzheimer's disease and therapeutic research.

Never before seen images of early stage Alzheimer's disease

March 13, 2017
Researchers at Lund University in Sweden have used the MAX IV synchrotron in Lund – the strongest of its kind in the world - to produce images that predate the formation of toxic clumps of beta-amyloid, the protein believed ...

BACE-Inhibitor successfully tested in Alzheimer's animal model

July 28, 2017
The protein amyloid beta is believed to be the major cause of Alzheimer's disease. Substances that reduce the production of amyloid beta, such as BACE inhibitors, are therefore promising candidates for new drug treatments. ...

Drug's effect on Alzheimer's may depend on severity of disease

July 16, 2014
A cancer drug that has shown promise against Alzheimer's disease in mice and has begun early clinical trials has yielded perplexing results in a novel mouse model of AD that mimics the genetics and pathology of the human ...

Recommended for you

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.